NeuroPace Inc Insider Trading for April 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NeuroPace Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NeuroPace Inc for April 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Option Exercise | C | 0.00 | 450,880 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Option Exercise | C | 0.00 | 21,486 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Buy | C | 0.00 | 472,366 | 0 | 565,657 | 93.3 K to 565.7 K (+506.34 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 3,605,386 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 171,895 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 3,777,281 | 0 | 4,012,281 | 235 K to 4 M (+1,607.35 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | Norton Evan | Director | Option Exercise | C | 0.00 | 3,454,422 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Norton Evan | Director | Buy | C | 0.00 | 3,454,422 | 0 | 4,042,657 | 588.2 K to 4 M (+587.25 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | Accelmed Partners II L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,454,422 | 0 | 3,454,422 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Accelmed Partners II L.P. | 10% Owner | Buy | C | 0.00 | 3,454,422 | 0 | 4,042,657 | 588.2 K to 4 M (+587.25 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Option Exercise | C | 0.00 | 5,271,902 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Option Exercise | C | 0.00 | 323,591 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Option Exercise | C | 0.00 | 18,032 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Option Exercise | C | 0.00 | 859 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Buy | C | 0.00 | 5,595,493 | 0 | 5,614,384 | 18.9 K to 5.6 M (+29,619.89 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Buy | C | 0.00 | 18,891 | 0 | 18,891 | 0 to 18.9 K |
Apr 26 2021 | NPCE | NeuroPace Inc | Favet Michael | Chief Executive Off ... | Option Exercise | C | 0.00 | 7,219 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Favet Michael | Chief Executive Off ... | Option Exercise | C | 0.00 | 343 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | Favet Michael | Chief Executive Off ... | Grant | A | 0.03 | 15,385 | 462 | 22,947 | 7.6 K to 22.9 K (+203.45 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | Favet Michael | Chief Executive Off ... | Buy | C | 0.00 | 7,562 | 0 | 7,562 | 0 to 7.6 K |
Apr 26 2021 | NPCE | NeuroPace Inc | LACOB JOSEPH | Director | Option Exercise | C | 0.00 | 205,497 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | LACOB JOSEPH | Director | Option Exercise | C | 0.00 | 102,747 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | LACOB JOSEPH | Director | Option Exercise | C | 0.00 | 17,189 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | LACOB JOSEPH | Director | Option Exercise | C | 0.00 | 8,594 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | LACOB JOSEPH | Director | Grant | A | 0.00 | 334,027 | 0 | 351,920 | 17.9 K to 351.9 K (+1,866.80 %) |
Apr 26 2021 | NPCE | NeuroPace Inc | KCK LTD. | 10% Owner | Option Exercise | C | 0.00 | 5,271,902 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | KCK LTD. | 10% Owner | Option Exercise | C | 0.00 | 323,591 | 0 | 0 | |
Apr 26 2021 | NPCE | NeuroPace Inc | KCK LTD. | 10% Owner | Buy | C | 0.00 | 5,595,493 | 0 | 5,621,111 | 25.6 K to 5.6 M (+21,842.04 %) |
Apr 23 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Option Exercise | A | 17.00 | 21,698 | 368,866 | 21,698 | |
Apr 23 2021 | NPCE | NeuroPace Inc | Garfield Greg Shaw | Director | Buy | P | 17.00 | 13,235 | 224,995 | 38,853 | 25.6 K to 38.9 K (+51.66 %) |
Apr 23 2021 | NPCE | NeuroPace Inc | Norton Evan | Director | Buy | P | 17.00 | 588,235 | 9,999,995 | 588,235 | 0 to 588.2 K |
Apr 23 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 235,000 | 3,995,000 | 235,000 | 0 to 235 K |
Apr 23 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 235,000 | 3,995,000 | 235,000 | 0 to 235 K |
Apr 23 2021 | NPCE | NeuroPace Inc | Ridley Irina | General Counsel and ... | Buy | P | 17.00 | 2,352 | 39,984 | 2,352 | 0 to 2.4 K |
Apr 23 2021 | NPCE | NeuroPace Inc | Ridley Irina | General Counsel and ... | Buy | P | 17.00 | 2,352 | 39,984 | 2,352 | 0 to 2.4 K |
Apr 23 2021 | NPCE | NeuroPace Inc | Accelmed Partners II L.P. | 10% Owner | Buy | P | 17.00 | 588,235 | 9,999,995 | 588,235 | 0 to 588.2 K |
Apr 23 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Option Exercise | A | 17.00 | 21,698 | 368,866 | 21,698 | |
Apr 23 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Buy | P | 17.00 | 50,000 | 850,000 | 93,291 | 43.3 K to 93.3 K (+115.50 %) |
Apr 23 2021 | NPCE | NeuroPace Inc | Accelmed Partners II L.P. | 10% Owner | Buy | P | 17.00 | 588,235 | 9,999,995 | 588,235 | 0 to 588.2 K |
Apr 23 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Option Exercise | A | 17.00 | 21,698 | 368,866 | 21,698 | |
Apr 23 2021 | NPCE | NeuroPace Inc | Fischer Frank M | Director | Buy | P | 17.00 | 50,000 | 850,000 | 93,291 | 43.3 K to 93.3 K (+115.50 %) |